Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma

ASIA unversity > 醫學暨健康學院 > 食品營養與保健生技學系 > 期刊論文 > Item 310904400/112913

請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/112913

題名:	Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma
作者:	林洧呈;Lin, Wei-Cheng;張家崙;Chang, Chia-Lun;許翰琳;Hsu, Han-Lin;吳駿紘;Wu, Alexander T. H.;袁聖博;Yuan, Kevin Sheng-Po;吳思遠;Wu, Szu-Yuan
貢獻者:	食品營養與保健生技學系
關鍵詞:	thoracic esophageal cancer;squamous cell carcinoma;intensity-modulated radiation therapy;concurrent chemoradiotherapy;three-dimensional conformal radiation therapy
日期:	2019-11
上傳時間:	2020-09-03 07:19:15 (UTC+0)
出版者:	亞洲大學
摘要:	Background: To date, intensity-modulated radiation therapy (IMRT) with concurrent chemoradiotherapy (CCRT) and CCRT with standard fractionation three-dimensional conformal radiation therapy (3D-CRT) have not been compared. In this study, the outcomes of IMRT-based concurrent CCRT and those of 3D-CRT-based CCRT were compared in patients with thoracic esophageal squamous cell carcinoma (TESCC). Methods: We enrolled 2062 patients with TESCC who had received CCRT and categorized them into two groups on the basis of their treatment modality: Group 1 (3D-CRT-based CCRT) and Group 2 (IMRT-based CCRT). Results: Multivariate Cox regression analysis indicated that the American Joint Committee on Cancer advanced stages (≥IIIA) and 3D-CRT were significant independent predictors of poor outcomes in patients with TESCC who received definitive CCRT. Moreover, receiving IMRT-based CCRT (adjusted hazard ratio [aHR]: 0.88, 95% confidence interval [CI]: 0.78–0.98) was a significant independent prognostic factor for overall survival (p = 0.0223). In Group 2, aHRs (95% CIs) for overall mortality at early (IA–IIB) and advanced clinical stages were 0.91 (0.67–1.25, p = 0.5746) and 0.88 (0.77–0.99, p = 0.0368), respectively. Conclusion: IMRT-based CCRT resulted in higher survival rates in patients with advanced clinical stages of TESCC (i.e., IIIA–IIIC), namely, clinical T3, clinical T4, or lymph node involvement.
關聯:	Cancers
顯示於類別:	[食品營養與保健生技學系] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	254	檢視/開啟

檢視Licence

在ASIAIR中所有的資料項目都受到原著作權保護.

資料載入中.....